Lataa...
Cellular and Tissue Distribution of Intravenously Administered Agalsidase Alfa
α-Galactosidase A is the lysosomal hydrolase that is deficient in patients with Fabry disease. Intravenous infusion of agalsidase alfa, a preparation of α-galactosidase A, is used for enzyme replacement therapy (ERT) in patients with Fabry disease. Although ERT appears to show some beneficial effect...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2006
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1839873/ https://ncbi.nlm.nih.gov/pubmed/17188539 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymgme.2006.11.008 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|